ID
38074
Beschreibung
Two-Part Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Oral Dosesof the Enteric-Coated Free Base Formulation of Darapladib (SB-480848) ina Dose Rising Fashion and to Evaluate the Safety, Tolerability and Pharmacokinetics of Darapladib when Co-administered with Ketoconazole in Healthy Adult Subjects. There are 4 parts to this study: Screening, Part A, Part B, and Follow-Up. Part A contains 2 Sessions per day for day 1-10, Part B contains 1 Session per day for day 1-14. Each itemgroup contains information when it should be filled out. The itemgroups of the non-serious and serious adverse event forms contain additional information on the definition of a serious/non-serious adverse event.
Stichworte
Versionen (1)
- 15.09.19 15.09.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
15. September 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Darapladib Evaluation Case Report Form GSK LPL107988
Serious Adverse Events
Beschreibung
Serious adverse event
Alias
- UMLS CUI-1
- C1519255
Beschreibung
Serious adverse event list
Alias
- UMLS CUI-1
- C1519255
- UMLS CUI-2
- C0745732
Beschreibung
Event
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0027365
Beschreibung
Start Date and Time
Datentyp
datetime
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C1519255
- UMLS CUI [2,1]
- C1301880
- UMLS CUI [2,2]
- C1519255
Beschreibung
Outcome
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C1274040
Beschreibung
If fatal, record date/time of death.
Datentyp
datetime
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0806020
- UMLS CUI [2,1]
- C1522314
- UMLS CUI [2,2]
- C1519255
Beschreibung
Maximum Intensity
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C1522410
- UMLS CUI [1,3]
- C0518690
Beschreibung
Action Taken with Investigational Product(s) as a Result of the SAE
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1547656
- UMLS CUI [1,2]
- C4688482
- UMLS CUI [1,3]
- C1519255
Beschreibung
Withdrawal
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1547656
- UMLS CUI [1,2]
- C1710677
- UMLS CUI [1,3]
- C1519255
Beschreibung
Relationship to Investigational Product(s)
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0332149
- UMLS CUI [1,2]
- C4688482
- UMLS CUI [1,3]
- C0678227
- UMLS CUI [1,4]
- C1519255
Ähnliche Modelle
Serious Adverse Events
C0681850 (UMLS CUI [1,2])
C2745955 (UMLS CUI [1,3])
C0745732 (UMLS CUI-2)
C0027365 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1301880 (UMLS CUI [2,1])
C1519255 (UMLS CUI [2,2])
C0806020 (UMLS CUI [1,2])
C1522314 (UMLS CUI [2,1])
C1519255 (UMLS CUI [2,2])
C1522410 (UMLS CUI [1,2])
C0518690 (UMLS CUI [1,3])
C4688482 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
C1710677 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
C4688482 (UMLS CUI [1,2])
C0678227 (UMLS CUI [1,3])
C1519255 (UMLS CUI [1,4])